MDS experts, Dr Alan List and Dr David Sallman, discuss the safety of blood and marrow transplantation (BMT) for myelodysplastic syndromes (MDS). Outcomes have improved in recent years, and more patients can now be considered for BMT. The success of the transplant and the severity of side effects vary from person to person, and can be difficult to predict. Talk to your doctor about whether BMT is an option for you.
Share with family and friends:
Click here to take our Myelodysplastic Syndromes (MDS) SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
This educational activity has been developed by
the Myelodysplastic Syndromes Foundation, Inc and Mechanisms in Medicine Inc.
This activity is supported by an educational grant from Acceleron Pharma, Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.